(Verbatim from Abstract) The long range goal of this project is to develop the biomedical potential of expanded porphyrins. The rich nature of this potential, although far from being fully tapped, is already beginning to be realized in the case of the texaphyrins. Currently, two different water soluble lanthanide(III) texaphyrin complexes, GD-Tex and Lu-Tex, are being tested clinically. The first of these, known by the trade name XCYTRIN(TM) and the generic name motexafin gandolinium, is in a pivotal Phase III clinical trial as a potential enhancer of X-ray radiation therapy (XRT) for patients with metastatic cancers to the brain. The second, to which the generic name motexafin lutetium has been assigned, is being tested in various formulations as a photosensitizer for use in (i) the photodynamic treatment of recurrent breast cancer (LUTRIN(TM); Phase II clinical trials complete), (ii) photoangioplastic reduction of atherosclerosis involving peripheral arteries (ANTRIN(TM); Phase II testing ongoing) and (iii) light-based treatment of age-related macular degeneration (OPTRIN(TM); currently in Phase I clinical trials). The cancer-related aspects of these trials, sponsored by Pharmacyclics, Inc., a company the PI helped co-found, are being complemented by numerous NCI-supported Phase I studies that are focused on such diverse and important indications as primary brain cancer, lung cancer, breast cancer, colrectal cancer and pancreatic cancer. The present application is designed to support these clinical trials while allowing the medically targeted chemistry of expanded porphyrins to become better developed. Specifically, funds are requested to enable the mechanism of the Gd-Tex-mediated XRT effect to be elucidated at both the chemical and biochemical levels and to allow for the synthesis of new bifunctional conjugates that exploit the biolocalizing properties of texaphyrins to effect the cancer-specific delivery of known cytotoxic agents. These same funds will also be used to prepare a number of new expanded porphyrins and to study existing ones with the goal of generating cancer-selective MRI contrast agents, tissue and disease specific fluorescent probes, and catalysts that function as superoxide dismutase mimics or act to decompose efficiently peroxynitrite. These latter species could prove useful in the treatment of ischemia and reperfusion injury.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA068682-13
Application #
6512783
Study Section
Metallobiochemistry Study Section (BMT)
Program Officer
Stone, Helen B
Project Start
1990-08-01
Project End
2005-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
13
Fiscal Year
2002
Total Cost
$328,185
Indirect Cost
Name
University of Texas Austin
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
City
Austin
State
TX
Country
United States
Zip Code
78712
Jung, Hyo Sung; Verwilst, Peter; Sharma, Amit et al. (2018) Organic molecule-based photothermal agents: an expanding photothermal therapy universe. Chem Soc Rev 47:2280-2297
Lee, Min Hee; Sharma, Amit; Chang, Min Jung et al. (2018) Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics. Chem Soc Rev 47:28-52
Jung, Hyo Sung; Lee, Jae-Hong; Kim, Kyutae et al. (2017) A Mitochondria-Targeted Cryptocyanine-Based Photothermogenic Photosensitizer. J Am Chem Soc 139:9972-9978
Jung, Hyo Sung; Han, Jiyou; Shi, Hu et al. (2017) Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach. J Am Chem Soc 139:7595-7602
Shin, Weon Sup; Han, Jiyou; Kumar, Rajesh et al. (2016) Programmed activation of cancer cell apoptosis: A tumor-targeted phototherapeutic topoisomerase I inhibitor. Sci Rep 6:29018
Thiabaud, Gregory; McCall, Rebecca; He, Guangan et al. (2016) Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator. Angew Chem Int Ed Engl 55:12626-31
Arambula, J F; McCall, R; Sidoran, K J et al. (2016) Targeting Antioxidant Pathways with Ferrocenylated N-Heterocyclic Carbene Supported Gold(I) Complexes in A549 Lung Cancer Cells. Chem Sci 7:1245-1256
Zhang, Huacheng; Lee, Juhoon; Lammer, Aaron D et al. (2016) Self-Assembled Pyridine-Dipyrrolate Cages. J Am Chem Soc 138:4573-9
Brown, Katherine A; Yang, Xiaoping; Schipper, Desmond et al. (2015) A self-assembling lanthanide molecular nanoparticle for optical imaging. Dalton Trans 44:2667-75
Lee, Min Hee; Kim, Jong Seung; Sessler, Jonathan L (2015) Small molecule-based ratiometric fluorescence probes for cations, anions, and biomolecules. Chem Soc Rev 44:4185-91

Showing the most recent 10 out of 51 publications